Search research articles
Contact Us
Filters
Showing results (41-50 of 62) with videos related to
Page
of 7
Sort By:
Cytokine
|
January 1, 1994
Interleukin 1 activity in haemolymph from strains of the snail Biomphalaria glabrata varying in susceptibility to the human blood fluke, Schistosoma mansoni: presence, differential expression, and biological function
W O Granath, V A Connors, R L Tarleton
The Journal of Protozoology
|
February 1, 1988
A monoclonal antibody to alpha tubulin recognizes host cell and Trypanosoma cruzi tubulins
J J Paulin, C H Keith, R L Tarleton
Infection and Immunity
|
February 1, 1981
Mitomycin C-treated Trypanosoma cruzi in vaccination of mice: induction of immunosuppression but not protection
R L Tarleton, R E Kuhn, D S Cunningham
Infection and Immunity
|
October 8, 1997
Glycosylphosphatidylinositols are required for the development of Trypanosoma cruzi amastigotes
N Garg, M Postan, K Mensa-Wilmot, et al.
International Archives of Allergy and Immunology
|
November 1, 1994
In vitro culture of cardiac mast cells from mice experimentally infected with Trypanosoma cruzi
M Postan, R Correa, V J Ferrans, et al.
Nature
|
March 26, 1992
Susceptibility of beta 2-microglobulin-deficient mice to Trypanosoma cruzi infection
R L Tarleton, B H Koller, A Latour, et al.
Circulatory Shock
|
March 1, 1990
Endotoxin-induced tumor necrosis factor activity production by equine peritoneal macrophages
D D Morris, J N Moore, K Fischer, et al.
The American Journal of Tropical Medicine and Hygiene
|
January 1, 1984
Diagnosis of Chagas' disease in humans using a biotin-3H-avidin radioimmunoassay
R L Tarleton, C L Schulz, M Grögl, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 20, 1998
Amastigote surface proteins of Trypanosoma cruzi are targets for CD8+ CTL
H P Low, M A Santos, B Wizel, et al.
International Immunology
|
January 1, 1996
Trypanosoma cruzi infection in MHC-deficient mice: further evidence for the role of both class I- and class II-restricted T cells in immune resistance and disease
R L Tarleton, M J Grusby, M Postan, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 62) with videos related to
Sort By:
Page
of 7
Cytokine
|
January 1, 1994
Interleukin 1 activity in haemolymph from strains of the snail Biomphalaria glabrata varying in susceptibility to the human blood fluke, Schistosoma mansoni: presence, differential expression, and biological function
W O Granath, V A Connors, R L Tarleton
The Journal of Protozoology
|
February 1, 1988
A monoclonal antibody to alpha tubulin recognizes host cell and Trypanosoma cruzi tubulins
J J Paulin, C H Keith, R L Tarleton
Infection and Immunity
|
February 1, 1981
Mitomycin C-treated Trypanosoma cruzi in vaccination of mice: induction of immunosuppression but not protection
R L Tarleton, R E Kuhn, D S Cunningham
Infection and Immunity
|
October 8, 1997
Glycosylphosphatidylinositols are required for the development of Trypanosoma cruzi amastigotes
N Garg, M Postan, K Mensa-Wilmot, et al.
International Archives of Allergy and Immunology
|
November 1, 1994
In vitro culture of cardiac mast cells from mice experimentally infected with Trypanosoma cruzi
M Postan, R Correa, V J Ferrans, et al.
Nature
|
March 26, 1992
Susceptibility of beta 2-microglobulin-deficient mice to Trypanosoma cruzi infection
R L Tarleton, B H Koller, A Latour, et al.
Circulatory Shock
|
March 1, 1990
Endotoxin-induced tumor necrosis factor activity production by equine peritoneal macrophages
D D Morris, J N Moore, K Fischer, et al.
The American Journal of Tropical Medicine and Hygiene
|
January 1, 1984
Diagnosis of Chagas' disease in humans using a biotin-3H-avidin radioimmunoassay
R L Tarleton, C L Schulz, M Grögl, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 20, 1998
Amastigote surface proteins of Trypanosoma cruzi are targets for CD8+ CTL
H P Low, M A Santos, B Wizel, et al.
International Immunology
|
January 1, 1996
Trypanosoma cruzi infection in MHC-deficient mice: further evidence for the role of both class I- and class II-restricted T cells in immune resistance and disease
R L Tarleton, M J Grusby, M Postan, et al.
Page
of 7